Comparison of imported drugs of Vancevi (valganciclovir) and potential domestic drugs

Valganciclovir (Valganciclovir), this antiviral drug against cytomegalovirus (CMV) infection, has always attracted much attention in the Chinese market. However, many patients may not know that the Vancevir (valganciclovir) currently available in the Chinese market is actually an imported original drug, and there is no domestic drug with the same ingredients on the market in China. Next, we’ll dive into the main differences between the two and the reasons behind them.

First of all, we have to understand what imported original drugs are. In short, this is a medicine manufactured by an original research and development company and produced in strict accordance with international standards. Valganciclovir (valganciclovir) imported into China falls into this category. It has gone through multiple rounds of clinical trials, and its quality and therapeutic effects have been widely recognized. At the same time, the production process of such drugs is also subject to multiple quality controls to ensure that every tablet is safe and reliable.

But behind high quality, there is often a relatively high price. Due to R&D costs, import taxes and other reasons, the selling price of imported Valganciclovir (valganciclovir) has reached more than 10,000 yuan in the Chinese market. This undoubtedly brings considerable financial pressure to many patients.

So, why are there no alternatives to Vancevir (valganciclovir) in China? There are three main reasons for this: first, domestic technology and experience in CMV drug research and development have yet to be accumulated; second, the group of CMV infected patients is relatively small, resulting in limited market demand; third, the patent protection of the original drug prevents other companies from copying it during the patent period.

However, it is gratifying that for patients with limited financial conditions, they can choose to purchase the original version of Vancevir (valganciclovir) from overseas, such as India or Turkey. The effects and ingredients of these versions of medicines are the same as those imported into China, but the prices are more affordable, about three to four thousand yuan.

To sum up, although theVansevir (valganciclovir) on the domestic market are all imported drugs and the price is relatively high, its excellent performance in treating and preventingCMV infection is still favored by the majority of patients and doctors. And for patients looking for a more affordable option, purchasing overseas may be a good alternative. When choosing drugs, patients should fully consult their doctors to ensure the best balance between the treatment effect and their own financial situation.